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DOI 10.1186/s12917-015-0333-9RESEARCH ARTICLE Open AccessCharacterisation of recent foot-and-mouth disease
viruses from African buffalo (Syncerus caffer) and
cattle in Kenya is consistent with independent
virus populations
Sabenzia Nabalayo Wekesa1,2, Abraham Kiprotich Sangula1, Graham J Belsham3, Kirsten Tjornehoj3,
Vincent B Muwanika2, Francis Gakuya4, Dominic Mijele4 and Hans Redlef Siegismund5*Abstract
Background: Understanding the epidemiology of foot-and-mouth disease (FMD), including roles played by different
hosts, is essential for improving disease control. The African buffalo (Syncerus caffer) is a reservoir for the SAT serotypes
of FMD virus (FMDV). Large buffalo populations commonly intermingle with livestock in Kenya, yet earlier studies have
focused on FMD in the domestic livestock, hence the contribution of buffalo to disease in livestock is largely unknown.
This study analysed 47 epithelia collected from FMD outbreaks in Kenyan cattle between 2008 and 2012, and 102
probang and serum samples collected from buffalo in three different Kenyan ecosystems; Maasai-Mara (MME)
(n = 40), Tsavo (TSE) (n = 33), and Meru (ME) (n = 29).
Results: Antibodies against FMDV non-structural proteins were found in 65 of 102 (64%) sera from buffalo with
44/102 and 53/102 also having neutralising antibodies directed against FMDV SAT 1 and SAT 2, respectively.
FMDV RNA was detected in 42% of the buffalo probang samples by RT-qPCR (Cycle Threshold (Ct) ≤32). Two
buffalo probang samples were positive by VI and were identified as FMDV SAT 1 and SAT 2 by Ag-ELISA, while
the latter assay detected serotypes O (1), A (20), SAT 1 (7) and SAT 2 (19) in the 47 cattle epithelia. VP1 coding
sequences were generated for two buffalo and 21 cattle samples. Phylogenetic analyses revealed SAT 1 and
SAT 2 virus lineages within buffalo that were distinct from those detected in cattle.
Conclusions: We found that FMDV serotypes O, A, SAT 1 and SAT 2 were circulating among cattle in Kenya
and cause disease, but only SAT 1 and SAT 2 viruses were successfully isolated from clinically normal buffalo.
The buffalo isolates were genetically distinct from isolates obtained from cattle. Control efforts should focus
primarily on reducing FMDV circulation among livestock and limiting interaction with buffalo. Comprehensive
studies incorporating additional buffalo viruses are recommended.
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Numerous species of cloven-hoofed wildlife and live-
stock, including buffalo, impala, cattle, sheep, goats and
pigs are affected by foot-and-mouth disease (FMD) [1].
The disease is clinically characterised by fever, lameness
and vesicular lesions on the tongue, feet, snout/muzzle
and teats of various susceptible species [2]. Globally, the
disease causing agent, FMD virus (FMDV), exists in
seven different serotypes (O, A, C, Asia 1, SAT 1, SAT 2
and SAT 3) and vaccination against (or infection with)
one serotype does not cross-protect against other sero-
types, hence the need for constant surveillance of circu-
lating strains for appropriate vaccine selection [3].
In the eastern Africa region, including Kenya, four of
the seven serotypes (O, A, SAT 1 and SAT 2) were pre-
viously known to circulate [4], but recently in 2013, SAT
3 was isolated from an apparently healthy long-horned
Ankole calf in Uganda [5]. This multiplicity of serotypes,
combined with the co-existence of a number of different
wild and domestic hosts within large geographical areas,
makes our understanding of the epidemiology and con-
trol of this disease complicated [6]. In eastern Africa,
existing policies largely comprise vaccination and live-
stock movement control. Infection by the virus may
result in substantial economic losses; these include pro-
duction losses (e.g. reduced milk yields, lameness in
draught animals, loss of weight, abortions, delayed con-
ception, peri-natal mortality) as well as effects from re-
strictions on sales and exports of livestock and livestock
products [7].
The severity of FMD varies from host to host, e.g.
cattle commonly suffer acute, clinically apparant infec-
tions [2], while in the African buffalo (Syncerus caffer)
the disease is usually subclinical [8,9] and hence is not
easy to detect. It has been reported that within wildlife,
the African buffalo are reservoirs for the SAT serotypes
[8,10] and may play a role in the maintenance and spread
of these serotypes to livestock [9] as reported in southern
Africa. Moreover, this buffalo species is capable of har-
bouring the virus for as long as 5 years within an indi-
vidual animal and for 24 years within a single herd [11].
Animals with these long-term infections are referred to
as persistently infected animals or carriers, and are
defined as animals in which the virus can be detected
from the oesophago-pharyngeal scrapings (OP/probang
sample) at 28 days or more after infection [12,13]. Un-
like in southern Africa, the role of the African buffalo
in the epidemiology of FMD is still unclear in eastern
Africa [14,15], yet buffalo interact with livestock, graz-
ing together in the vast and numerous un-fenced wild-
life ecosystems.
It has been argued that wildlife might act as a source
of sporadic disease occurrence in livestock with negative
impacts on the harmonious co-existence of these species[16,17]. On the one hand, there is experimental evidence
that FMD may spread from buffalo to cattle, while on
the other hand, there is a lack of adequate supportive
scientific evidence for the role of wildlife in the epidemi-
ology of FMD in livestock [18]. Indeed, some studies
have argued that FMD may be predominantly a disease
of livestock [17,19] and that the spread of FMDV among
livestock may be more associated with human activities
than with wildlife [20]. Moreover, the importance of
enhancing our understanding of disease spread at the
wildlife-livestock interface and the need to balance
biodiversity management with livestock production have
been emphasized previously [16,21]. It is therefore
necessary to study the disease spread at this interface to
ensure that appropriate policies and control measures
are implemented. This should help to protect the wild-
life heritage and concurrently promote harmonious,
profitable and sustainable livestock-wildlife interaction.
According to unpublished Kenya Wildlife Service
(KWS) records, Kenya has an estimated total population
of 26,325 buffalo distributed among numerous parks, re-
serves, sanctuaries and ranches found within several major
ecosystems including Tsavo, Meru, Laikipia/Samburu,
Amboseli, Nakuru and Maasai-Mara. This buffalo po-
pulation and other less susceptible wildlife species com-
plements the numerous domestic FMDV-susceptible
hosts in Kenya, including 17.5 million cattle, 27.7 mil-
lion goats, 17.1 million sheep and 300,000 domestic pigs
recorded during the 2009 national animal census [22]. Re-
cords at the national Foot-and-Mouth Disease Laboratory
(FMDL), Embakasi, show that previous studies on FMD in
Kenya have been mainly focused on cattle and not other
susceptible domestic species such as pigs [23] and only to
a minor extent on wildlife. However, in 1979, a field sur-
vey isolated SAT 1 and SAT 2 FMDVs from buffalo popu-
lations in the southern part of Kenya [24], while a more
recent study (1994-2002) established a higher seropreva-
lence of antibodies against FMDV in buffalo than in other
susceptible wildlife species, but also highlighted some
limitations of the specificity of the serological tests that
were used [25].
Elsewhere in the east African region, studies of buffalo
within neighbouring Uganda’s Queen Elizabeth National
Park isolated SAT 3 virus in 1997 [26], reported anti-
bodies against FMDV serotypes O, SAT 1, SAT 2 and
SAT 3 in sera collected during 2001-2003 [15], and suc-
cessfully isolated and genetically characterized SAT 1
and SAT 2 viruses in 2005-2008 [27].
This study, aimed at determining the presence of anti-
bodies against different serotypes of FMDV within buf-
falo populations in selected wildlife ecosystems in Kenya
and at comparing FMDV isolates from these buffalo
populations with the FMDVs found in cattle within this
country and elsewhere in Africa. The study endevoured
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regarding FMDV circulation in eastern Africa.Methods
Ethical approval
This study was ethically approved by the Kenya Wildlife
Services (permit no. KWS/BRM/5001) and undertaken
in collaboration with the Department of Veterinary
Services (DVS) of the Ministry of Livestock Development
in Kenya under the Transboundary Animal Diseases in
East Africa (TADEA) project, DFC no. 10-006KU.Samples from buffalo
The buffalo sampling was carried out between March
and July 2012. The study was designed as a cross-
sectional study targeting buffalo populations interacting
with domestic animals regardless of their age. The buf-
falo were clustered into three major buffalo ecosystems
located within four out of the eight major administra-
tive regions/provinces of Kenya (North-Eastern, Eastern,
Rift Valley and Coast) (Figure 1). These include the Meru
ecosystem (ME), represented by Meru National Park, the
Maasai-Mara ecosystem (MME), represented by Maasai-
Mara National Reserve and the Tsavo ecosystem (TSE),
represented by Tsavo East National Park. These ecosys-
tems have estimated populations of 4069, 3030 and 7281
buffalo, respectively, according to the KWS records.
Within these ecosystems, there is a high level of inter-
action between livestock and wildlife. MME and TSE have
open savannah-type vegetation, which eases the capture
and handling of the animals, while ME has patches of
wooded grassland vegetation.
Two groups of veterinarians and technicians in two
separate vehicles carried out the buffalo sampling; one
identified the herds and chemically immobilized the ani-
mals as described by [28], while the other traced, marked
and sampled the immobilized animals, taking records of
geographical location, age by dentition [29], sex, clinical
signs, body condition and estimated herd size. Two or
three animals per herd were randomly selected to enable
sampling of as many herds as possible.
In total 102 serum and corresponding probang sam-
ples were collected from buffalo; these comprised sam-
ples from MME (n = 40), TSE (n = 33) and ME (n = 29)
with approximate animal ages ranging between 8 months
and 19 years. The probang samples were diluted 1:1 in
phosphate buffered saline (PBS) (pH 7.2) supplemented
with 0.01% bovine serum albumin (BSA), 0.002% phe-
nol red and 0.25% antibiotics (Pen-Strep-Neo, Sigma-
Aldrich, St. Louis, MO, USA), stored in liquid nitrogen
and transported to FMDL, Embakasi, where they were
stored at −80°C.Samples from cattle
Taking into consideration the time of sampling, quality
of material and the geographical source with a focus on
districts around ecosystems of interest for this study and
the sampling period (2008-2012), cattle epithelial sam-
ples were selected from the repository of all Kenyan field
samples at the FMDL, Embakasi (Figure 1 and Table 1).
Testing strategy
This study compared evidence of infection by FMDV in
buffalo and cattle using serological and virological assays
as recommended by the OIE terrestrial manual [30]. All
serological tests (except VNT for antibodies against SAT
3) were performed at FMDL, Embakasi, while all tests
on epithelia from cattle and probang samples from
buffalo, including sequencing were performed at the
National Veterinary Institute, Lindholm, Denmark.
Buffalo sera were screened for antibodies against FMDV
non-structural proteins (NSPs) as an indicator of prior in-
fection with FMDV. Serotype-specific antibody titres were
initially determined using liquid phase blocking ELISAs
(LPBEs) (for antibodies against all FMDV serotypes ex-
cept Asia 1). Thereafter (due to expected cross-reactivity
among ELISAs [31-33]), VNTs, which exhibit lower level
of cross-reactivity [31,32], were performed for neutralizing
antibodies against six serotypes of FMDV (all except Asia 1).
All buffalo probang samples were tested using the 3D
coding region-targeted real time RT-PCR (3D RT-qPCR)
assay and virus isolation (VI) was attempted. Harvests of
samples that induced cytopathic effect (CPE) in primary
bovine thyroid (BTY) cells were tested in antigen ELISA
(Ag-ELISA) and in 5’UTR-targeted real time RT-PCR
(5’UTR RT-qPCR). Harvests positive in Ag-ELISA and
with sufficient FMDV RNA to generate an amplicon cor-
responding to the VP1 coding sequence were character-
ized by sequencing. Cattle epithelia were tested directly
in the Ag-ELISA and using the 5’UTR RT-qPCR assay
and when amplicons could be generated directly were
sequenced.
Laboratory methods
Detection of antibodies against FMDV non-structural
proteins (NSPs) in buffalo sera
All 102 buffalo sera were screened using the Prio-
CHECK® FMDV NS kit (Prionics AG, Switzerland) to
detect antibodies against the NSPs of FMDV. The assay
was performed according to the manufacturer’s instruc-
tions. Sera were tested using a 1:5 dilution and optical
density (OD) measured at wavelength 450 nm (OD450
test sample). The results were expressed as Percentage
Inhibition (PI) relative to the negative control (OD450
max) as follows: PI = 100 − [OD450 test sample/OD450
max)] × 100. Sera with PI <50 were considered negative
and sera with PI ≥50% positive.
Figure 1 Map of Kenya showing sampled wildlife ecosystems (shaded), administrative regions (underlined) and districts. Circles with numbers
indicate geographic origins of the 15 SAT 1 and SAT 2 foot-and-mouth disease viruses (FMDVs) isolated from buffalo and cattle sample analysed in this
study. The numbers correspond to the serial numbers in Table 1. The map was created using ArcGIS (ArcMap v 9.3) copyright 2008 ESRI.
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1 Ken/TSE1/2012 31/07/2012 Buffalo Taita Coast SAT 1 17.19a SAT 1 KP263443
2 K159/2012 19/12/2012 Cattle Meru Eastern SAT 1 24.1b SAT 1 KP263444
3 K127/2011 01/12/2011 Cattle Taita-Taveta Coast SAT 1 9.96 SAT 1 KP263445
4 K56/2010 24/03/2010 Cattle Laikipia Rift Valley SAT 1 24.48 SAT 1 KP263446
5 KenMMB37/2012 25/02/2012 Buffalo Narok Rift Valley SAT 2 25.12 SAT 2 KP263447
6 K146/2012 31/10/2012 Cattle Nakuru North Rift Valley SAT 2 14.66 SAT 2 KP263448
7 K125/2012 05/09/2012 Cattle Kisii Nyanza SAT 2 14.6 SAT 2 KP263449
8 K126/2012 09/10/2012 Cattle Nakuru Rift Valley SAT 2 15.64 SAT 2 KP263450
9 K53/2012 25/05/2012 Cattle Kericho Rift Valley SAT 2 17.79 SAT 2 KP263451
10 K26/2012 21/02/2012 Cattle Narok South Rift Valley SAT 2 10.44 SAT 2 KP263452
11 K28/2012 25/02/2012 Cattle Nyandarua Central SAT 2 13.57 SAT 2 KP263453
12 K10/2012 20/01/2012 Cattle Bomet Rift Valley SAT 2 23.11 SAT 2 KP263454
13 K46/2012 27/04/2012 Cattle Nakuru North Rift Valley SAT 2 15.7 SAT 2 KP263455
14 K128/2011 01/12/2011 Cattle Nyandarua Central SAT 2 19.37 SAT 2 KP263456
15 K30/2012 28/02/2012 Cattle Subukia Rift Valley SAT 2 14.03 SAT 2 KP263457
16 K138/2012 05/10/2012 Cattle Gilgil Rift Valley A 11.31 A KJ440872
17 K143/2012 19/10/2012 Cattle Naivasha Rift Valley A 24.13 A KJ440873
18 K148/2012 13/11/2012 Cattle Nakuru North Rift Valley A 19.29 A KJ440874
19 K154/2012 03/12/2012 Cattle Koibatek Rift Valley A 23.5 A KJ440875
20 K3/2013 09/01/2013 Cattle Thika East Central A 22.56 A KJ440876
21 K63/2009 31/03/2009 Cattle Narok South Rift Valley A 25.75 A KJ440871
22 K73/2008 23/08/2008 Cattle Loitokitok Rift Valley A 23.17 A KJ440870
23 K33/2010 01/12/2010 Cattle Ijara North Eastern O 25.75 O KP765607
24 K10/2009 26/01/2009 Cattle Machakos Eastern A 28.65 N/A N/A
25 K14/2013 28/01/2013 Cattle Sotik Rift Valley A No Ct N/A N/A
26 K140/2012 12/10/2012 Cattle Koibatek Rift Valley A 30.12 N/A N/A
27 K144/2012 25/10/2012 Cattle Sotik Rift Valley A 29.44 N/A N/A
28 K151/2012 26/11/2012 Cattle Subukia Rift Valley A 26.69 N/A N/A
29 K152/2010 07/12/2010 Cattle Transmara Rift Valley A 25.4 N/A N/A
30 K160/2012 28/12/2012 Cattle Rongai Rift Valley A 27.41 N/A N/A
31 K18/2013 31/01/2013 Cattle Rongai Rift Valley A 16.74 N/A N/A
32 K2/2013 09/01/2013 Cattle Mogotio Rift Valley A 16.43 N/A N/A
33 K5/2013 10/01/2013 Cattle Murang’a Central A 18.38 N/A N/A
34 K64/2010 04/06/2010 Cattle Narok Rift Valley A 36.78 N/A N/A
35 K7/2013 16/01/2013 Cattle Nakuru Rift Valley A 27.58 N/A N/A
36 K88/2010 14/05/2010 Cattle Githunguri Central A 31.86 N/A N/A
37 K43/2011 19/03/2011 Cattle Suba Nyanza SAT 1 29.12 N/A N/A
38 K78/2011 26/08/2011 Cattle Lamu West Coast SAT 1 28.21 N/A N/A
39 K8/2011 01/07/2011 Cattle Nyeri South Central SAT 1 23.64 N/A N/A
40 K84/2012 07/03/2012 Cattle Kathonzweni Eastern SAT 1 13.77 N/A N/A
41 K113/2012 09/08/2012 Cattle Mathioya Central SAT 2 25.69 N/A N/A
42 K122/2011 23/11/2011 Cattle Njoro Rift Valley SAT 2 25.65 N/A N/A
43 K127/2012 12/09/2012 Cattle Kisumu East Nyanza SAT 2 24.62 N/A N/A
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Table 1 List of the 49 FMD viruses analysed in this study (Continued)
44 K33/2012 01/03/2012 Cattle Njoro Rift Valley SAT 2 24.06 N/A N/A
45 K39/2012 16/03/2012 Cattle Kenyanya Nyanza SAT 2 28.08 N/A N/A
46 K54/2012 31/05/2012 Cattle Mashuru Rift Valley SAT 2 21.16 N/A N/A
47 K55/2012 04/06/2012 Cattle Koibatek Rift Valley SAT 2 28.86 N/A N/A
48 K78/2012 28/06/2012 Cattle Naivasha Rift Valley SAT 2 22.07 N/A N/A
49 K98/2012 22/07/2012 Cattle Nyandarua West Central SAT 2 9.9 N/A N/A
*No. 1-15 correspond to the numbers in Figure 1 showing the geographic origin of the 15 SAT 1 and SAT 2 cattle and buffalo FMD viruses sequenced and
compared in this study, while No. 1-23 indicate all the 23 FMD viruses that were successfully sequenced in the entire study.
N/A - Not applicable since the sequence was not determined.
**Sample reference number: the letter (K) indicates the first letter of the name of the country of origin (Kenya), followed by the serial number of the isolate and
the year of sampling.
aCt value for buffalo samples based on 3D RT-qPCR assay.
bCt value for all cattle samples based on 5’UTR RT-qPCR assay.
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liquid phase blocking ELISA (LPBE) in buffalo sera
The LPBE assay was performed on all 102 buffalo serum
samples using a commercial kit (BDSL, Scotland, UK),
in accordance with the OIE manual [30]. The antigens
used for this assay were: O1 Manisa, A22 IRQ 24/64, C
PHI 7/84, SAT 1 (105), SAT 2 Eritrea, SAT 3 (309), and
Asia 1 Shamir as contained in the kit. The sera were
tested in two-fold dilution series from 1/32 to 1/256.
The results were expressed as the reciprocal of the last
positive dilution (the titre); samples with titres ≥90 were
considered positive in accordance with instructions in
the OIE manual.
Assay for neutralising antibodies against FMDV in
buffalo sera
VNTs were performed to detect neutralizing antibodies
against six serotypes (all except Asia 1) on all the 102
buffalo sera to confirm the LPBE results and to clarify
possible cross-reactions as described in the OIE manual
[30]. Briefly, quadruplicate two-fold dilution series of
serum samples were incubated for 1 hr in flat-bottomed
tissue culture grade microtitre plates with about 100
TCID50 of each of the Kenyan FMDV vaccine strains
(O K77/78, A K5/80, C K267/67, SAT 1 T155/71, SAT
2 K52/84) and a Zimbabwean SAT 3 isolate (SAT 3 ZIM
4/81). The use of these old isolates was based on previ-
ous experience [23] and their satisfactory performance
during the annual World Reference Laboratory (WRL)
proficiency tests. Subsequently, a suspension of baby
hamster kidney (BHK) cells was added to the samples
followed by incubation for 2 days at 37°C. For SAT 3,
incubation was in primary swine kidney (SK) cells for
3 days at 37°C. The controls included titration of a
standard positive serum, cell control and a ten-fold
titration of the virus suspension. The final end point
titres were calculated as described previously [34] and
titres ≥45 were considered positive, 16-44 doubtful
and <16 negative [30].Serological data recording and statistical analysis
Serological results were recorded and descriptive statis-
tics calculated in MS Excel 2007 (Microsoft Corpor-
ation). Analyses of estimated prevalences and Confidence
Intervals were performed using the Survey toolbox soft-
ware [35].
Epithelial and probang sample processing and virus
isolation (VI)
All epithelia and probang samples were thawed at room
temperature and processed as recommended in the OIE
manual [30]. Epithelial samples from cattle were ground
in Eagles minimum essential media supplemented with
protein hydrolysate, 2% fetal calf serum and antibiotics
(2 million I.U. benzyl-penicillin, 1 g dihydrostreptomycin
sulphate, 0.5 g neomycin sulphate, 1 g streptomycin and
8.5 μg amphotericin per litre) using sterile sand, mortar
and pestle to make a 10% (w/v) suspension. These ly-
sates were tested directly in the Ag-ELISA and used for
RNA extraction, RT-qPCR and sequencing (see below).
Probang suspensions from buffalo were inoculated onto
BTY cells for 1 hour at 37°C followed by a change of
media and continued incubation. The cultures were exa-
mined after 24 and 48 hours and harvested when CPE
developed. The CPE negative samples were harvested by
freeze-thawing and inoculated onto fresh cells for an-
other 48 hours. CPE positive samples were harvested,
while cultures negative after 2 passages were discarded.
Positive harvests were tested in the Ag-ELISA and tested
in the 5’UTR RT-qPCR assay (see below).
Detection of FMDV RNA using quantitative real time RT-PCR
(RT-qPCR)
Quantitative RT-qPCR assays targeting the FMDV 3D cod-
ing sequence of the FMDV RNA were performed on buffalo
probang samples as described previously [36] using a
Superscript III/Platinum Taq one-step RT-qPCR kit (PE
Biosystems, Life Technologies, Carlsbad, California, USA)
with 3D probe (5′-FAM-TCCTTTGCACGCCGTGGGAC-
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CCTGTGA-3′) and reverse primer (5′-GCGAGTCCTGC
CACGGA-3′). In addition, RT-qPCR assays targeting the
FMDV 5’ UTR were performed on all the 47 cattle epithelia
and CPE positive buffalo harvests using TaqMan® Universal
2X PCR Master Mix (PE Biosystems, Life Technologies,
Carlsbad, California, USA). The PCR was run, as described
previously [37], using the FMDV MultiII IRES primers
(FMDV Multi II forward primer and FMDVMulti II reverse
primer) and FMDVMulti II-288 probe (FAM-labelled).Antigen detection ELISA (Ag-ELISA)
Ag-ELISA to detect the presence of FMDV was performed
as described in the OIE manual [30] and by [38], and,
when positive, to determine the serotype. Samples with
an OD difference between sample and negative control
of >0.2 were considered positive, while those between
0.1 and 0.2 were considered inconclusive and repeated.Sequencing of the FMDV VP1 coding region
Viral RNA was extracted from Ag-ELISA positive
harvests of cell culture generated using buffalo probang
samples and cattle epithelia samples. This was achieved
by using the QIAmp® RNA blood mini kit (Qiagen,
Hamburg, Germany) following the protocol for extrac-
tion of total RNA as described by the manufacturer. The
RNA was eluted using 60 μl of RNase-free water and
stored at -80°C. It was tested using the 5′UTR RT-
qPCR assay. For selected RNAs the Ready-To-Go You-
Prime First-Strand beads (GE Healthcare Life Sciences,
Uppsala, Sweden) were used to synthesize new cDNA
with random hexamer primers (pdN6).
The FMDV cDNA sequences were amplified using the
reverse primer 1.0 PN 15 (NK-72) [39] and forward
primers 1.0-U PN E (AKS-2) [40] or 13-KPN 100 or 13-
KPN 101 (Table 2). The latter two primers were
designed from the sequences of the Kenyan SAT 1
(K127/2011) and SAT 2 (K10/2012) cattle samples from
this study, respectively. The PCRs were performed as de-
scribed previously [41] and the products (≈840 bp) were
analysed by electrophoresis on 1.5 % agarose gels (Seakem
GTG agarose in 1 X TAE - low EDTA buffer) at 120 volts
for 30 min. in parallel with a 1 kb DNA ladder GeneRuler®
(Fermentas, Vilnius, Lithuania).Table 2 Primers used for amplification of FMDV VP1 cDNA in
Primer name Sequence (5ˈ-3ˈ)
1.0 PN 15 (NK-72) (reverse) GAAGGGCCCAGGGTTGGACTC
13-KPN 100 (forward) GGGTGGBBGTSTWMCAGRTSACMGACA
13-KPN 101(forward) CACTGCTAYCAYKCNGARTGGGA
1.0-U PN E (AKS-2) (forward) TTAACTACCACTTCATGTACACXG
V = A,C,G; H = A,C,T; B = C,G,T; S = C,G; W = A,T; M = A,C; R = A,G; Y = C,T; K = G,T; N =PCR products were purified using SigmaSpin® Sequen-
cing Reaction Clean-Up Columns (Sigma-Aldrich, St.
Louis, MO, USA) following the manufacturer’s instruc-
tions. Quantification of products and cycle sequencing
were performed as previously described [41]. Cycle se-
quencing in both directions was achieved using the same
forward and reverse primers as for the RT-PCRs.Sequence assembly, alignment and analysis
The nucleotide sequences were assembled and edited
using SeqMan Pro software (DNAstar, Inc., Madison,
WI, USA). Serotype identification of the sequences was
achieved by comparison with Genbank data using the
Basic Local Alignment Search Tool (BLAST) [42].
The buffalo and cattle VP1 coding sequences gener-
ated in this study were compared to selected FMDV
SAT 1 and SAT 2 sequences from Kenyan cattle deter-
mined in previous studies, from the WRLFMD [43] and
from Genbank (see list in Additional file 1: Table S1
and Additional file 2: Table S2). Sequence alignment
was achieved using MUSCLE [44] incorporated in
MEGA software version 5.2 [45] and trimmed to 639
nucleotides encompassing the complete VP1 coding
region of the viral RNA genome. Substitution models
were also determined in MEGA5.2 as earlier described
[41], briefly, Maximum Likelihood fits of 24 different
nucleotide substitution models were estimated and Akaike
Information Criterion (AIC) was used. Non-uniformity
evolution rates were modelled using discrete gamma dis-
tribution (G) and the Tamura Nei substitution model with
gamma distribution and invariable rates (I) (TN93 +G + I)
was chosen [45]. The evolutionary history was inferred
using the neighbor-joining method [45] and a bootstrap
consensus tree estimated from 1000 replicates [46]. Per-
centage nucleotide differences among taxa in the data sets
were calculated using MEGA5.2 [45] and genetic distances
compared using the P-distance.Results
None of the 102 buffalo sampled in this study had clin-
ical signs suggestive of FMDV infections during the sam-
pling, while all the 47 cattle samples analysed were from
animals with apparent clinical signs of FMD (data not
shown).this study
Isolate of origin Reference
Accession no. AJ 539141 Mason et al., 2003 [35].
C K127/2011 This study
K10/2012 This study
Accession no AY593849 Sangula et al., 2010 [36].
Any; X = Inosine.
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buffalo sera
Out of 102 buffalo sera tested, 65 (64%) had antibodies
against FMDV NSPs; these were distributed between the
three different ecosystems as follows: MME 36/40 (90%:
CI = 84–100%); ME 17/29 (59%: CI = 51–71%) and TSE
12/33 (36%: CI = 22–40%) (Table 3).
Serotype-specific antibodies against FMDV in buffalo sera
detected by LPBE
Generally, antibodies were detected by the LPBE against
each of the six FMDV serotypes tested for (O, A, C, SAT
1, SAT 2 and SAT 3). Only three of the 102 buffalo sam-
ples were negative (with titres ≤90) for antibodies against
all six serotypes tested for by LPBE, while 15, 15, 10, 19,
19 and 21 samples were positive for antibodies against
all six, five, four, three, two and one serotype, respect-
ively (data not shown). Moreover, high antibody titres
(≥256) against serotypes O, A, SAT 1, SAT 2 and SAT 3
were found in 33, 20, 37, 39 and 29 sera, respectively
(data not shown). The positive samples were distributed
in the three ecosystems in different proportions as indi-
cated in Table 3, i.e. SAT 2 dominating in MME, O/SAT
3 in ME and SAT 1/O in TSE.
Detection of neutralising antibodies against FMDV by
VNT in buffalo sera
The buffalo sera were also tested in VNT assays. In con-
trast to the LPBE results, there was no evidence for the
presence of neutralising antibodies against FMDV sero-
types C and SAT 3 among the 102 buffalo in the three
ecosystems. Only one and two sera had neutralizing an-
tibodies against serotypes O and A, respectively; more-
over, these three sera had higher or equal titres against
SAT 1 and/or SAT 2 and thus the apparent presence of
anti-O and anti-A antibodies may result from cross re-
activity in the assays. In contrast, neutralising antibodies
against serotypes SAT 1 and SAT 2 were detected in 44/
102 (43%) and 53/102 (52%) samples, respectively. Thirty
of these samples were positive for antibodies against
both serotypes and generally had higher titres against
SAT 2 than against SAT 1, while 14 and 23 samples onlyTable 3 Detection of FMDV RNA and antibodies against FMD









aMME 40 Feb. 22 36 16
bME 29 March 6 17 25
cTSE 33 Aug. 15 12 29
Total 102 43 65 70
aMaasai-Mara Ecosystem; bMeru Ecosystem; cTsavo Ecosystem; dVNT assay did not d
both SAT 1 and SAT 2.had antibodies against SAT 1 or SAT 2, respectively
(Table 3). Altogether 67 sera had neutralising antibodies
against FMDV, including 41 of the 65 sera with anti-
bodies against NSP, meaning that 24 and 26 sera only
were positive in one of these test systems (data not
shown). The distribution of the positive sera between
the three ecosystems is shown in Table 3. MME and ME
had higher levels of neutralising antibodies against SAT
2 than against SAT 1, while TSE predominantly had SAT
1 neutralising antibodies.Presence of FMDV and FMDV RNA in buffalo probang
samples
Among the buffalo probang samples, 43/102 (42%) had
evidence of FMDV RNA as detected by the 3D RT-
qPCR assay on the original, non-passaged samples
(Table 3) with Ct values ≤32 and were distributed as fol-
lows: MME (22/40), ME (6/29) and TSE (15/33). Twenty
seven of these 43 (63%) positive samples came from buf-
falo with neutralising antibodies against FMDV SAT 1
and/or SAT 2.
The 43 buffalo probang samples that were positive in
the 3D RT-qPCRs were inoculated onto BTY cells.
Thirty three of these samples induced CPE, but only two
of the cell harvests tested positive in the FMDV Ag-
ELISA and were identified as SAT 1 and SAT 2, respect-
ively (data not shown). Moreover, only these same two
cell culture harvests (from MME and TSE) contained
significant levels of FMDV RNA (Ct values of 17.19 and
25.12, Table 1) in the 5’UTR RT-qPCR assay and were
used for VP1 sequencing following RT-PCR.Presence of FMDV antigen and RNA in cattle epithelia
All the 47 cattle epithelium samples (directly tested
without virus isolation) were positive on Ag-ELISA, and
their distribution between the serotypes was as follows:
O (1); A (20); SAT 1 (7) and SAT 2 (19) (Table 1). All but
two of the 47 cattle epithelial samples had Ct values <32
and amplicons corresponding to the VP1 coding sequence
were successfully generated and sequenced from 21 of
them (Table 1).V in buffalo from selected wildlife ecosystems in Kenya
the 3 ecosystems per test
per serotype (titres ≥90) dVNT per serotype
A C SAT 1 SAT 2 SAT 3 SAT 1 only SAT 2 only eSAT 1
& SAT 2
10 5 15 34 12 11 18 8
16 3 10 16 19 4 14 3
27 11 32 24 19 29 21 19
53 19 57 74 50 44 53 30
etect any antibodies against FMDV serotypes O, A, C and SAT 3. ePositive for
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A total of 23 FMDV VP1 coding region sequences were
successfully generated in this study (Table 1). These
comprised two buffalo sequences (generated after VI)
and 21 cattle sequences (directly sequenced from epithe-
lial suspensions without VI). The buffalo sequences were
identified as FMDV SAT 1 and SAT 2 originating from
TSE and MME, respectively, while the 21 cattle se-
quences were identified as O (1), A (7), SAT 1 (3) or
SAT 2 (10). The serotype identification, based on the
sequence comparison (using BLAST), of samples from
both species corresponded to the Ag-ELISA results. The
cattle viruses originated from various parts of the coun-
try and for the purpose of this study, only the 3 serotype
SAT 1 and the 10 SAT 2 cattle sequences were included
in the phylogenetic analysis presented here, while the
serotype O and A sequences were analysed elsewhere
[41,47] (Table 1).
Statistical analysis and interpretation of FMDV
prevalences in buffalo
The overall prevalence of antibodies against FMDV in
buffalo as determined from the NSP assays was 64%,
and the detection of FMDV RNA in probang samples by
3D RT-qPCR was 42%. Thirty seven of the 43 (86%)
animals with FMDV RNA in the pharynx also had
antibodies against FMDV NSPs, while six buffalo had
FMDV RNA in their pharynx without being antibody
positive and 28 buffalo had antibodies against NSP with-
out FMDV RNA in the pharynx (data not shown). The
two positive buffalo isolates came from animals that had
RNA in the pharynx, had antibodies against NSPs and
were sero-positive (on VNT assay) for the same sero-
types (SAT 1 and SAT 2) of virus.
VP1 coding sequence analysis in this study
A total of 73 FMDV SAT 1 and 75 SAT 2 VP1 coding
sequences (including the 15 SAT 1 and SAT 2 FMDV se-
quences generated in this study) were analysed in com-
bination with sequences derived from other FMDVs
originating in Kenya, other countries in eastern Africa
and also other regions of Africa that were available from
Genbank and WRLFMD (see Additional file 1: Table S1
and Additional file 2: Table S2). The estimated phylogen-
etic trees, using the Neighbor-Joining method, for the
SAT 1 and SAT 2 virus sequences are shown in Figures 2
and 3 respectively.
The four SAT 1 VP1 coding sequences generated in
this study comprised one (KenTSE1/2012) that was
collected from a buffalo in TSE in Taita district, coast
province, and three that were collected from cattle in
different areas, namely Taita-Taveta (K127/2011), Laikipia
in Rift Valley province (K56/2010) and Meru in Eastern
Province (K159/2012) (Table 1, Figures 1 and 2). The2012 buffalo isolate (KenTSE1/2012) clustered within
the same topotype (I-NWZ) as both recent and older
FMDV cattle isolates from Kenya but belonged to a
separate, independently evolving lineage, from the cat-
tle isolates (Figure 2). However, it shared a recent com-
mon ancestor with some recent Kenyan cattle viruses
including K159/2012, K56/2010 and some of the 2009
group of viruses. Within the VP1 coding sequences, the
buffalo KenTSE1/2012 isolate had 11%, 10% and 9% nt
difference from these recent Kenyan cattle virus se-
quences, respectively. In addition, KenTSE1/2012 had
10% and 13% nt difference from the isolate found in
cattle in the same district (Taita) (K127/2011) and from
the current vaccine strain (T155/1971), respectively.
This buffalo isolate also had >10% nt difference from
the other cattle viruses collected in 2010-2011 from
various districts in various regions of the country (data
not shown). It is also noteworthy that these recent SAT
1 cattle sequences clustered within a separate lineage from
the current vaccine strain. When compared to other Afri-
can buffalo derived FMDV sequences, it was apparent that
the KenTSE1/2012 belonged to a separate topotype (I-
NWZ) (Figure 2). This isolate had 27% nt difference from
the 2007 buffalo isolate from neighbouring Uganda
(UGA/1/2007), 23% nt difference from the 1990 buffalo
isolates from Zimbabwe (ZIM/3/1990 and ZIM/13/1990)
and 24% nt difference from those collected in Kruger
National Park (KNP/148/1991 and KNP/41/1995) in
South Africa (data not shown).
The SAT 2 VP1 coding sequences included 11 se-
quences generated in this study (Table 1). These com-
prised 10 cattle sequences from various regions of the
country and one buffalo sequence (KenMMB37/2012)
from MME in Narok district of the Rift Valley province.
The buffalo isolate grouped within the same topotype
(IV) as some Tanzanian cattle viruses from 2004 and the
Kenyan cattle viruses, including the viruses from 2004-
2005 and 2007-2008, but has evolved as an independent
lineage (Figure 3). Moreover, this Kenyan buffalo isolate
also belonged to a different lineage from the current
vaccine strain (SAT 2 K52/1984) (Figure 3) with 14% nt
difference (data not shown) in this part of the genome.
Comparisons of this buffalo isolate with the recent
2011-2012 cattle viruses showed >13% nt difference. It
was also notable that, these recent SAT 2 cattle isolates
clustered within a separate lineage (within topotype IV)
than the current vaccine strain (Figure 3). Compared to
the other buffalo sequences in eastern Africa, KenMMB
37/2012 belonged to a different topotype (IV) and had
on average >21% nt difference from the recent buffalo
SAT 2 Ugandan viruses (UGA/1/2007 and UGA/2/2007)
that grouped within East Africa topotype X (Figure 3).
Similarly, this Kenyan buffalo SAT 2 virus belonged to a








Figure 2 (See legend on next page.)
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Figure 2 Neighbor-Joining tree depicting one Kenyan foot-and-mouth disease virus (FMDV) SAT 1 buffalo sequence from this study
(●) compared to recent SAT 1 Kenyan cattle sequences from this study (▲) and from World Reference Laboratory for FMD (WRLFMD)
(◄); recent Ugandan buffalo sequence (UGA/1/2007); the current Kenyan vaccine strain (■); older Kenyan cattle sequences from
WRLFMD (with prefix “KEN”) and Genbank; and selected cattle and buffalo sequences from eastern and southern Africa obtained from
GenBank and listed in the Additional file 1: Table S1. Sequences from buffalo species are marked with an asterisk (*). Only Bootstrap test
values above 70 are shown on the branches. Topotypes are indicated on the branches by the prefix I-NWZ for one topotype and by Roman
numbers for the rest.
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and had on average, 20-30% nt differences from these
viruses (data not shown).
Discussion
This study has characterised and compared FMDVs that
have recently infected buffalo and cattle in Kenya using
a combination of assays. The PrioCHECK® FMDV NS
ELISA demonstrated an overall seroprevalence of anti-
bodies against FMDV NSPs of 64% in the studied
Kenyan buffalo populations, which is comparable to the
68 % recorded by [25] in buffalo in eastern Africa but
lower than the 74% and 85% reported in Ugandan buf-
falo in 2001-2003 and 2005-2008, respectively [15,27].
For comparison, the seroprevalence in Kenyan cattle in
2010 was 52.5% [48]. The NSP antibody seroprevalence
varied between the three investigated ecosystems, with
the highest recorded in MME followed by ME and lastly
TSE; this is comparable to the reported variation in
buffalo NSP antibody seroprevalence between Ugandan
national parks [15,27].
Serotype-specific LPBE identified high titres (≥90) of
antibodies against each of the six FMDV serotypes tes-
ted for, however, essentially only the antibodies against
FMDV SAT 1 and SAT 2 were confirmed by VNT, sug-
gesting high levels of cross-reactions in the commercial
LPBE assay that was used. Such cross-reactions have
been experienced using other serotype-specific antibody
ELISAs in buffalo populations in Uganda [15,27] and in
eastern Africa [25], as well as with sera from FMDV in-
fected cattle with fresh or healing lesions (1-14 days after
infection) [41,49]. However, clearer results have been ob-
tained using SPBE in domestic ruminants sampled 2-4
months after infection [38,49] and in pigs sampled dur-
ing an outbreak of SAT 1 in Kenya [23]. Moreover, since
individual buffalo and buffalo herds are known to carry
and maintain FMDV infections for a long time [11], it is
likely that they are continuously exposed to FMDVs,
resulting in the existence of animals with multiple pre-
vious infections by the virus. Therefore, high levels of
cross-reactivity are to be expected due to boosting of
antibodies against shared epitopes between the serotypes
[50]. Consequently, the serotype-specific ELISAs may not
be expected to give clear results in free-ranging Africanbuffalo, underpinning the necessity of collecting and se-
quencing the circulating FMDVs from this species [26,41].
It is noteworthy that none of the sampled buffalo in
this study had clinical signs suggestive of FMD, despite
the fact that 42% (based on Ct ≤32) of the probang sam-
ples were positive for FMDV RNA by RT-qPCR. Fur-
thermore, SAT 1 and SAT 2 FMDVs were each isolated
from buffalo probang samples. This is not surprising
because infection in African buffalo with FMDV has been
known to be largely sub-clinical [8]; thus our results con-
cur with previous studies in the region [15,27] and with
three experimental infection studies in buffalo [51-53].
In this study, we isolated and characterised two FMD
viruses, one SAT 1 and one SAT 2, from buffalo probang
samples, while serotypes O (1), A (7), SAT 1 (3) and
SAT 2 (10) FMDVs, respectively, were characterised dir-
ectly from epithelial samples from acutely infected cattle
from different regions of Kenya. These findings agree
with previous reports that have found these four sero-
types in circulation in Kenyan cattle [4] and confirm the
continued presence of multiple serotypes of FMDV in
Kenya since FMD was first diagnosed in 1932 [43]. In
addition, the study also found that the recent SAT 1 and
SAT 2 FMDVs in cattle and buffalo were divergent from
the current vaccine strains, consistent with findings for
serotypes O and A [41,47]. This finding raises concerns
regarding the effectiveness of currently available vaccine
strains against circulating viruses, suggesting the need
for vaccine matching.
Among the SAT serotypes, the occurrence of SAT 3
FMDV has been mainly associated with buffalo and neu-
tralising antibodies against SAT 3 have previously been
demonstrated (albeit in lower proportions than the other
SATs) in buffalo populations in Kenya [25], while in
neighbouring Uganda both antibodies [15,26,27] and virus
[26] have been reported in buffalo. Furthermore, the pres-
ence of SAT 3 virus in a long horned Ankole calf in
Uganda has recently been reported for the first time [5].
Interestingly, the current study did not find SAT 3 FMDV
or neutralising antibodies against SAT 3 (by VNT), neither
among cattle nor within the buffalo populations in the
three ecosystems studied within Kenya. These findings are
consistent with reports from the WRLFMD [43] and re-
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Figure 3 Neighbor-Joining tree showing one Kenyan foot-and-mouth disease virus (FMDV) SAT 2 buffalo sequence from this study (●)
compared to recent SAT 2 Kenyan cattle sequences obtained in this study (▲) and from World Reference Laboratory for FMD
(WRLFMD) (With the prefix “KEN”); recent buffalo sequences from Uganda (UGA/1/2007 and UGA/2/2007); the current Kenyan vaccine
strain (■); older Kenyan cattle sequences from WRLFMD (◄) and from Genbank; and cattle and buffalo sequences from eastern Africa
and southern Africa obtained from GenBank and listed in the Additional file 2: Table S2. Sequences from buffalo species are marked with
an asterisk (*). Only Bootstrap test values above 70 are shown on the branches. Topotypes are indicated by Roman numbers on the branches.
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dence for the presence of serotype C in either buffalo or
cattle. This serotype has not been isolated in Kenya since
2004 [54], although some serological evidence (subject to
the caveats about antibody ELISA cross-reactivity) for
exposure to this serotype has been found recently among
cattle in Kenya [55], buffalo in neighbouring Uganda [27]
and regionally among cattle in Eritrea [56] and Ethiopia
[57]. There is a need for wider and more comprehensive
studies among all FMDV susceptible species to verify the
absence of these two serotypes in the country, considering
the widespread movement of livestock and wildlife within
and across national borders.
FMDV isolation, antigen detection ELISA and sequen-
cing have been commonly performed on cattle samples
in Kenya but rarely in other susceptible species (wildlife
included) as is evident from the records of the FMDL,
Embakasi, the WRLFMD [43] and from a recent study
[23]. In the present study, the antigen ELISA and
sequencing were fully consistent with each other. Taken
together with the serological data, this study provided
evidence that FMDV serotypes SAT 1 and SAT 2 are in
circulation within the three buffalo ecosystems studied.
This finding is consistent with an earlier field survey in
1979 among buffalo in MME and cattle around this
ecosystem which isolated FMDV SAT 1 and SAT 2 from
buffalo [24].
Guided by the principles published for SAT viruses
that nt differences >20% define separate topotypes [58],
this study found that although the SAT 1 buffalo virus
identified in this study clustered within the same topo-
type (I-NWZ) as both recent and older FMDV isolates
from Kenya, it belonged to a separate independently
evolving lineage. Interestingly, even one virus (K127/
2011) from cattle in the same district (Taita-Taveta) as
the SAT 1 buffalo isolate did not group within the same
lineage. However, the phylogenetic tree also showed that
although this buffalo virus has been evolving independ-
ently from the cattle viruses, they originated from a
common ancestor (Figure 2), suggestive of an ancestral
species jump [10]. A similar trend was observed with the
SAT 2 buffalo isolate KenMMB37/2012 collected from
MME that belonged to the same topotype (IV) as both
recent and earlier SAT 2 Kenyan cattle viruses but
had ≥13% nt difference from them, including a recentvirus from Narok district (K126/2012) in which MME is
located (Figure 3).
These findings (albeit with a very small number of buf-
falo viruses) are consistent with the idea that there may
be largely independent cycles of FMDV circulations in
Kenya; one that occurs within buffalo populations and
another within livestock populations, concurring with
earlier observations indicating that eastern Africa may
be experiencing these separate FMDV cycles [59]. This
idea is also consistent with the absence of evidence from
the current study of other serotypes circulating among
buffalo populations either from virological or serological
assays, yet serotypes O and A were frequently found in
cattle.
The findings in this study contribute to the debate of
whether FMD is mainly a disease of livestock in endemic
Africa [17]. On the one hand, natural transmission from
buffalo to livestock has been demonstrated in Zimbabwe
[60,61] and South Africa [9], on the other hand, the real
risks posed by carrier animals to susceptible hosts have
not been adequately quantified [62]. However, the results
presented here indicate that although other serotypes
(O and A), together with SAT 1 and SAT 2 FMDVs are
constantly circulating in Kenyan cattle, buffalo mainly
harbour SAT serotypes. The current Kenyan findings
are in agreement with previous studies in eastern Africa
[24,25,27] and consistent with wildlife playing a limited
role in the epidemiology of FMD in cattle in eastern
Africa. However, owing to the limited number of buf-
falo viruses in our data set, it is not possible to draw
firm conclusions.
Conclusions
This study found that four serotypes of FMDV (O, A,
SAT 1 and SAT 2 circulate among cattle in different
regions of Kenya. Buffalo species were found to harbour
SAT 1 and SAT 2 serotypes with no virological or sero-
logical evidence for other serotypes. Moreover, there was
no evidence for the recent occurrence of serotypes C
and SAT 3 in cattle or buffalo. The identified African
buffalo virus lineages in the wild have apparently evolved
separately from lineages found in livestock in Kenya
and in the region. Hence, FMD control in Kenya should
primarily focus on reducing the high virus burden
among livestock and subsequently limit the association
Wekesa et al. BMC Veterinary Research  (2015) 11:17 Page 14 of 15of livestock with wildlife. However, due to the limited
data in this study, there is need for more comprehen-
sive research incorporating a larger number of buffalo
viruses and deeper analysis including evolutionary track-
ing of the origins of the viruses to determine the role of
buffalo in the epidemiology of this disease.
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